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At the end of lactation the mammary gland undergoes involution,
a process characterized by apoptosis of secretory cells and tissue
remodelling. To gain insight into this process, we analysed the
gene expression profile by oligonucleotide microarrays during
lactation and after forced weaning. Up-regulation of inflammatory
mediators and acute-phase response genes during weaning was
found. Expression of IκBα (inhibitory κBα), a protein known
to modulate NF-κB (nuclear factor-κB) nuclear translocation,
was significantly up-regulated. On the other hand, there was a
time-dependent degradation of IκBα protein levels in response to
weaning, suggesting a role for NF-κB. Furthermore, we have
demonstrated, using chromatin immunoprecipitation assays,
binding of NF-κB to the NOS-2 (inducible nitric oxide synthase)
promoter at the early onset of events triggered during weaning.
The three isoforms of NOS are constitutively present in the
lactating mammary gland; however, while NOS-2 mRNA and
protein levels and, consequently, NO production are increased
during weaning, NOS-3 protein levels are diminished. Western
blot analyses have demonstrated that protein nitration is increased
in the mammary gland during weaning, but this is limited to a
few specific tyrosine-nitrated proteins. Interestingly, inhibition
of GSH synthesis at the peak of lactation partially mimics
these findings, highlighting the role of NO production and GSH
depletion during involution.
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INTRODUCTION
Involution of the mammary gland is characterized by an increase
in the number of apoptotic events in the epithelia of the lobulo–
alveolar compartment soon after weaning [1]. This is followed
by proteolytic degradation of the basement membrane and major
remodelling of the mammary gland [1]. The changes observed du-
ring mammary gland involution are controlled at the transcrip-
tional level by circulating hormones and locally derived factors
[2]. Although the molecular signals that initiate involution remain
to be identified, changes in the pattern of expression of a number
of transcription factors and stress response genes have been
observed [3–5]. Furthermore, inflammatory mediators and acute-
phase response genes have also been shown to be up-regulated
during involution [4,5]. In addition, several transcription factors
that are known to regulate the transition from lactation to invol-
ution in the mammary gland, including JunB [5], Stat3 (signal
transducer and activator of transcription 3) [4,5], Stat5 [3]
and NF-κB (nuclear factor-κB) [4], were also found to be differ-
entially expressed after weaning. Nonetheless, these data alone
cannot discern the signalling events and molecular mechanisms
connecting hormonal stimuli and local factors with the trans-
cription of target genes. In this sense, we have shown that
GSH levels in the mammary gland play a prominent role in the
maintenance of lactation, and that a decrease leads to apoptosis
and involution of the mammary tissue [6,7]. GSH status has been
described as being involved in the modulation of NF-κB activity
in a wide variety of cell types [8].
As mentioned above, NF-κB is known to be involved in
mammary gland involution; furthermore, this transcription factor
plays an important role in controlling the immune and inflammat-
ory responses [9]. In mammalian cells, there are several mem-
bers of the NF-κB/Rel family. The classic form of NF-κB, a
heterodimer of the p50 and p65 subunits, is retained in the
cytoplasm through interactions with IκB inhibitory proteins.
Inducing stimuli lead to the phosphorylation and degradation
of IκB, allowing NF-κB to enter the nucleus and regulate gene
expression [9,10]. Following its degradation, IκB is transcrip-
tionally up-regulated, since IκB is an NF-κB target gene [9,11].
In the mouse mammary gland during pregnancy, the DNA-
binding activity of NF-κB (p50/p65) is increased until day 16
post coitum and decreases with the onset of lactation [10,12].
Similarly, the activity of an NF-κB-dependent luciferase reporter
gene in transgenic mice was demonstrated to be maximal during
pregnancy, decreased to near undetectable levels during lactation,
and increased again during involution [13]. This up-regulation
of NF-κB led us to question whether NF-κB has a role in the
signalling events that trigger involution of the mammary gland,
and, if so, what would be the target genes for this transcription
factor. Active NF-κB, in turn, is known to be involved in the
transcriptional modulation of over 150 genes. Most of the proteins
encoded by NF-κB target genes participate in the stress and
host immune responses, such as NOS-2 (nitric oxide synthase-
2) [14]. In this regard, it is generally believed that modulation of
NOS-2 transcription is the most important component of NOS-
2 regulation, and that NF-κB seems to be a central target for
activators or inhibitors of its expression [15].
Nitric oxide (NO) regulates several physiological events [16]
by means of rapid responses, such as blood flow, blood pressure
and smooth muscle contraction. NO has also been shown to act
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as a signal that regulates gene expression, apoptosis, cell cycle
arrest and differentiation [17]. NO is synthesized from L-arginine
and O2 by NOS. Three distinct isoforms have been identified [18]:
neuronal NOS (NOS-1), inducible NOS (NOS-2) and endothelial
NOS (NOS-3). The concentration and source of NO are the major
factors determining its biological effects. In fact, while basal NO
production by constitutive NOS isoforms (NOS-1 and NOS-3)
has a physiological role, at high concentrations the reactive
species derived from NO mediate the deleterious effects of this
molecule [19]. The potential consequence of producing large
amounts of NO may be local cytotoxicity, favouring processes
such as apoptosis, which is characterized by up-regulation of the
tumour suppressor p53, cytochrome c release from mitochondria,
activation of caspases, changes in the expression of pro- and anti-
apoptotic Bcl-2 family proteins, chromatin condensation and
DNA fragmentation [20].
The presence of NOS in the lactating mammary gland has been
demonstrated by immunohistochemistry [21]. In various exper-
imental models, high levels of exogenous NO induce apoptosis
via a caspase/cytochrome c-dependent mechanism [22]. In the
present paper we explore some of the molecular mechanisms
behind the initial events triggered during involution. We demon-
strate that, during weaning, NF-κB translocates to the nucleus,
where it binds to the NOS-2 promoter, inducing its expres-
sion, which explains the increase in NO production observed
after litter removal. Since we have already demonstrated that
GSH is essential for the maintenance of lactation, we hypothesize
that GSH might play an important role in the modulation of NO
production.
EXPERIMENTAL
Animals and tissue extraction
Pregnant Wistar rats were kept in individual cages in a controlled
environment (12 h light/12 h dark cycle) and received water and
food ad libitum. The rats were cared for and handled in accordance
with the NIH guidelines and the Guiding Principles for Research
Involving Animals and Humans approved by the Council of The
American Physiological Society. The Research Committee of
the School of Medicine (University of Valencia, Valencia, Spain)
approved the study protocol.
Following parturition, litters were maintained with at least 10
pups. At day 12 of lactation, the rats were divided into five groups:
control lactating rats (n = 6) at the peak of lactation (days 12–15);
two groups of weaned rats, where pups were removed 12 days
after delivery to initiate involution; the weaning took place 8
and 24 h before the rats were killed (n 3 for each condition);
rats at the peak of lactation that had been weaned for 24 h
followed by resuckling for another 24 h (n = 3); and lactating
rats (n = 4) treated with BSO (buthionine sulphoximine; Sigma
Chemical Co.) over a period of 2 days (4 mmol/kg, twice a day
intraperitoneally) to lower GSH levels.
The rats were anaesthetized with sodium pentobarbital (60 mg/
kg body wt. in 0.9% NaCl, intraperitoneal; Abbott Laboratories)
and killed immediately after removal of the inguinal mammary
glands.
GSH determination
The freeze-clamped tissue was powered in liquid nitrogen, and
aliquots of 1 g were extracted with 4 vol. (v/w) of 6% HClO4
by homogenization with a motor-driven Teflon homogenizer. The
extract was centrifuged at 1500 g for 10 min to remove proteins,
and the final supernatant was used to measure GSH using the
glutathione S-transferase method [23].
Isolation of acini
Acini were prepared by a modification of the procedure of Katz
et al. [24]. For full details, see Robinson and Williamson [25].
RNA extraction and PCR analysis
Total RNA from mammary tissue or isolated acini was ex-
tracted using TRIzol reagent (Invitrogen Life Technologies).
Quantitative RT-PCR (reverse transcription–PCR) was performed
in one step using the TTh DNA polymerase kit (Roche
Diagnostics). The mRNA expression was studied by real-time
PCR (iCycler iQ real-time PCR detection system) using specific
oligonucleotides for NOS-2 (5′-TGTGACACACAGCGCTA-
CAA-3′ and 5′-TGTTGAAGGCGTAGCTGAAC-3′) and GAP-
DH (glyceraldehyde-3-phosphate dehydrogenase) (5′-GGGTCA-
TCATCTCTGCACCT-3′ and 5′-GGTCATAAGTCCCTCCAC-
GA-3′). mRNA detection was carried out by measuring the
binding of the fluorescent dye SYBR Green I to double-stranded
DNA. GAPDH expression was used as an internal control. The
threshold cycle (CT) was determined, and then relative gene
expression was expressed as follows:
Change in expression (fold) = 2−(CT)
where CT = CT (target) − CT (housekeeping), and (CT) =
CT (treated) −CT (control).
ChIP (chromatin immunoprecipitation) assays
Chromatin from mammary gland acini was fixed and immuno-
precipitated according to Borra´s et al. [26]. Briefly, isolated acini
were treated with 1% (v/v) formaldehyde for 8 min to cross-link
the chromatin, and the reaction was stopped by adding glycine to a
final concentration of 0.125 M. After centrifugation at 1500 g for
5 min, the cell pellet was resuspended in cell lysis buffer (85 mM
KCl, 0.5% Nonidet P40, 5 mM Hepes, pH 8.0) supplemented
with a protease inhibitor cocktail (Sigma), incubated on ice for
15 min and centrifuged at 3500 g for 5 min to pellet the nuclei.
The pellet was resuspended in nuclear lysis buffer (10 mM EDTA,
1% SDS, 50 mM Tris/HCl, pH 8.1) at a ratio of 1:1 (v/w) relative
to the initial tissue weight, incubated on ice for 10 min, aliquotted
in 1 ml fractions and stored at −80 ◦C until use for ChIP assay.
Cross-linked chromatin (1 ml of each sample) was sonicated
on ice with 10 pulses of 10 s at 40% amplitude in a Vibra-Cell
VCX-500 sonicator. The average size of the chromatin fragments
obtained was ∼500 bp. The sonified chromatin was centrifuged
at 14000 g for 10 min and the supernatants, containing soluble
chromatin fragments, were diluted 10-fold with dilution buffer
(165 mM NaCl, 0.01%SDS, 1.1%Triton X-100, 1.2 mM EDTA,
16.7 mM Tris/HCl, pH 8.0) supplemented with protease inhibitor
cocktail. The diluted chromatin fractions were precleared by
adding 30 µl/ml Protein A/G–agarose (Amersham Biosciences;
previously blocked for 1 h with 100 µg/ml λ-DNA, 500 µg/ml
tRNA and 1 mg/ml BSA) and kept for 4 h at 4 ◦C on a rotating
plate. The suspensions were then centrifuged at 14000 g for 30 s
to remove non-specifically bound chromatin fragments. Aliquots
from the supernatant (equivalent to 50 µg of DNA) were taken,
incubated with 2 µg of specific antibodies against the NF-κB
p65 subunit and an antibody against RNA polymerase II (both
from Santa Cruz Biotechnology), and left overnight at 4 ◦C under
rotation. The samples were then incubated with 50 µl of blocked
Protein A/G–agarose under rotation for an additional period of 4 h.
The immunocomplex was recovered by centrifugation at 14000 g
for 30 s and washed as described previously [27]. An aliquot
of the cross-linked chromatin was treated as above, but in the
absence of the antibody (No Ab fraction); the first supernatant,
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after preclearing with Protein A/G–agarose, was saved as the Input
fraction. The immunoselected chromatin was eluted from the
Protein A/G–agarose in two consecutive steps by adding 100 µl of
elution buffer (1% SDS, 100 mM NaHSO3) each time, with 30 s
of vigorous vortexing. The two supernatants were combined [IP
(immunoprecipitated) fraction] and incubated at 65 ◦C overnight
to reverse formaldehyde cross-links. The DNA from all samples
was purified with a PCR purification kit (Qiagen) and used for
PCR analysis of the target genes.
PCR analysis of immunoprecipitated chromatin
After DNA purification, the Input, IP and No Ab fractions were
analysed by PCR with the appropriate primer pairs to amplify
products of 180–300 bp in length, corresponding to either the
promoter or the coding regions of the target genes. For the ana-
lysis, 1:5000 dilutions of the Input and 1:30 dilutions of the
IP and No Ab fractions were used. Primers for PCR ana-
lysis were as follows: NOS-2 (promoter region), 5′-AGCGGCTC-
CATGACTCTCA and 5′-TGCACCCAAACACCAAGGT-3′; α-
actin (promoter region), 5′-AGGGACTCTAGTGCCCAACACC-
3′ and 5′-CCCACCTCCACCCTACCTGC-3′; NOS-2 (coding
region), 5′-ACTGGACCACCGCTGTCAGG-3′ and 5′-CCTG-
CTTTGCCACTTGCCAG-3′.
PCR fragments were size-fractionated by 2% (w/v) agarose
gel electrophoresis and stained with ethidium bromide.
Preparation of samples for GeneChip hybridization
Mammary glands from two different groups of rats were selected
for this study: those after 12 days of lactation and those at 8 h
after forced weaning on day 12 of lactation. Samples for chip
hybridization were prepared according to protocols supplied by
Affymetrix. Briefly, after isolation of acini from mammary glands
under various conditions, total RNA was extracted using TRIzol
reagent followed by additional column purification (Rneasy;
Quiagen).
GeneChip hybridization and data analysis
Samples of total RNA (5 µg) from each condition were used
for the production of biotinylated cRNA according to the
manufacturer’s protocol (Affymetrix). The quality of the labelled
cRNA was confirmed by hybridization to an Affymetrix test chip
(Test3-chip). All experiments were performed in triplicate with
RNA from three individual rats. Labelled cRNA was hybridized
to an Affymetrix RG-U34A chip. The raw data were analysed by
Microarray Suite 5.0 software.
Each of the three experiments using tissue from the weaned
rats was compared with each of the three experiments using tissue
from rats at day 12 of lactation (used as a baseline), to produce a
total of nine comparisons. Only probe sets that produced at least
seven out of nine change values of P 0.0024 were considered
as showing increased expression (or P 0.9976 for decreased
expression). Only genes with a fold change in expression of1.5
were selected, and classified according to the biological process
category or first subcategory in which they are involved, following
the criteria of the Gene Ontology Consortium [28].
Protein extraction and immunoblotting analysis
The freeze-clamped tissue (0.1 g) was homogenized in 1 ml of
extraction buffer as described previously [6]. The lysates were
normalized for protein concentration using the BCA protein assay
reagent (Pierce Chemical Co.). Equal amounts of protein (10 µg)
were loaded in SDS/PAGE gels and analysed by Western blot as
described [6]. The antibodies used were: rabbit polyclonal anti-
NOS-1 (Affinity Bioreagents; ABR), rabbit polyclonal anti-NOS-
2 and anti-NOS-3 (both from Santa Cruz Biotechnology); mouse
monoclonal anti-nitrotyrosine (Calbiochem); rabbit polyclonal
anti-IκBα and anti-IκBβ (both from Santa Cruz); and mouse
monoclonal α-tubulin (Santa Cruz).
Nitrite determination
The assay used was that described by Misko et al. [29] for the
fluorimetric determination of nitrite. The method is based on the
reaction of 2,3-diaminonaphthalene (Sigma Chemical Co.) with
nitrite under acidic conditions to form 1-(H)-naphthotriazole, a
fluorescent product. Samples were prepared by homogenizing
0.1 g of tissue in 10 ml of 50 mM Tris/HCl, pH 7.5, followed
by centrifugation at 19000 g for 10 min. An aliquot of 10 µl of
freshly prepared 2,3-diaminonaphthalene (0.05 mg/ml in 0.62 M
HCl) were added to 100 µl of the supernatant and mixed im-
mediately. After a 10 min incubation at 20 ◦C protected from light,
the reaction was stopped with 5 µl of 2.8 M NaOH. Formation
of the 2,3-diaminonaphthotriazole was measured using a fluor-
escent plate reader, with excitation at 365 nm and emission read
at 450 nm. White opaque 96-well plates (Bibby Sterilin Ltd.) were
used for optimal measurement of fluorescence intensity.
Statistical analysis
ANOVA was performed to analyse the data in Figures 3, 4 and
5. The homogeneity of the variances was analysed by the Levene
test; in those cases in which the variances were unequal, the data
were adequately transformed before ANOVA. The null hypothesis
was accepted for all values of these sets in which the F-value was
non-significant at P > 0.05. The data for which the F-value
was significant were examined by Tukey’s test at P < 0.05.
RESULTS
Expression profile analysis in mammary glands of rats at the peak
of lactation and 8 h after weaning
In order to gain a better understanding of the signalling events
triggered during the early onset of involution, we performed a
transcript analysis using Affymetrix oligonucleotide microarrays
at the peak of lactation and 8 h after litter withdrawal on day 12
of lactation (Figure 1A; see also Supplementary Table 1 and
Supplemetary Figure 1 at http://www.BiochemJ.org/bj/391/
bj3910581add.htm). Analysis of gene expression profiles revealed
a decrease in the expression of genes involved in the metabolism
of glucose and lipogenesis de novo during involution of the
mammary gland; these results correlate with metabolic studies
done in the 1970s, in which a decrease in lipogenesis was de-
scribed in the mammary gland after lactation [30]. Among the
genes that were up-regulated during weaning, those encoding
inflammatory mediators and acute-phase proteins were identified,
in accordance with previous reports [4,5]. As expected, expression
of genes involved in cell death, such as those encoding Stat3,
caspase-6 and Smac/Diablo, was increased during weaning,
whereas genes encoding anti-apoptotic proteins (Dad-1, Bcl-2,
etc.) were down-regulated.
It is interesting to note that IκBα mRNA was significantly
up-regulated during weaning (Figure 1B). Since IκBα gene
expression is usually up-regulated after degradation of the protein,
due to the fact that IκBα is a target gene of activated NF-κB [10],
our results indirectly suggested that NF-κB was activated after
weaning. Therefore we determined whether weaning induced IκB
protein degradation. In general, IκBα is rapidly degraded after
cellular activation, whereas other IκB proteins (IκBβ and IκBε)
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Figure 1 Differential gene expression in mammary glands from control lactating rats and after weaning
(A) Three complementary microarray experiments show differential gene expression in mammary glands from rats after weaning compared with that in control lactating glands. Genes down- and
up-regulated after weaning are represented by solid and empty bars respectively. Genes with a fold change in expression of 1.5 were classified according to the category of biological process
in which they are involved, following the criteria of the Gene Ontology Consortium [26]. The number of entries in a category relative to the total number of entries in the RG-U34A chip is given in
parentheses. (B) The profile of IκBα expression was studied in control mammary glands (C) and 8 h after weaning (W 8h.); the values are normalized mean probe intensities for the three microarray
experiments. (C) Effects of weaning on IκBα and IκBβ protein levels. Western blot analysis of equal amounts (20 µg) of protein derived from control lactating mammary gland (C) and mammary
glands 8 h (W 8h.) or 24 h (W 24h.) after weaning were probed with anti-IκBα and anti-IκBβ antibodies as described in the Experimental section.
are degraded with slower kinetics. As shown in Figure 1(C), we
found that IκBα degradation was induced as early as 8 h after litter
removal, and was maximal at 24 h. However, IκBβ protein levels
did not change during weaning, as this protein is more stable.
Active NF-κB binds to the NOS-2 promoter, modulating its
transcription in the mammary gland after weaning
NF-κB is activated in mammary epithelium by targeted de-
gradation of its repressor IκBα. To determine the in vivo nuclear
protein binding of NF-κB to the NOS-2 promoter region, ChIP
assays were performed with an affinity-purified antibody directed
against p65 (Figure 2A). DNA was extracted from the Input, IP
and No Ab fractions; equal amounts from each fraction were
amplified using primers specific for the NOS-2 promoter region.
Binding was determined by the relative intensity of ethidium
bromide fluorescence when compared with the input control. Our
data show that binding of NF-κB to the NOS-2 promoter was
evident at 8 h after weaning, whereas it was almost undetectable
during lactation. Binding to the α-actin promoter (used as
a negative control) was not observed (Figure 2A), indicating
specific binding of NF-κB to the NOS-2 promoter.
In order to determine if NF-κB binding is involved in the
transcription of NOS-2, the same cross-linked chromatin samples
used for the ChIP assay with the anti-p65 antibody were also used
for ChIP with an antibody against RNA polymerase II [27].
Briefly, the chromatin was immunoprecipitated with anti-(RNA
polymerase II) antibody and specific primers of the coding region
of the desired gene were used for DNA amplification. A positive
result means that the gene is being currently transcribed. As shown
in Figure 2(B), no signal was observed using mammary gland
from lactating rats; however, after weaning, the RNA polymerase
was bound to the coding region of the NOS-2 gene. Binding to
α-actin (used as a negative control) was not observed (Figure 2B),
indicating specific binding of RNA polymerase II to the NOS-2
gene.
The presence of NF-κB bound to the NOS-2 promoter during
weaning suggests that this transcription factor modulates the
expression of NOS-2, and the concomitant binding of the RNA
polymerase II to the coding region reflects the current transcription
of the NOS-2 gene.
Inducible NOS mRNA expression is increased during weaning and
after GSH depletion
Our results suggested a possible induction of NOS-2 expression
in the mammary gland following weaning. In order to deter-
mine whether weaning modulates NOS-2 expression, real-time
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Figure 2 Analysis of NOS-2 gene expression in mammary glands from
lactating rats and 8 h after weaning: in vivo NF-κB binding to the promoter
and current transcription of the gene
Immunoprecipitation of formaldehyde-cross-linked chromatin was carried out using samples
from control mammary glands (lactating) and 8 h after weaning with specific antibodies against
the p65 subunit (A) or RNA polymerase II (B). Immunoprecipitates were aliquotted and
subsequently analysed by PCR with specific primers for either the NOS-2 promoter (A) or
the NOS-2 coding region to study the current transcription of the gene (RNA polymerase II ChIP
assay; B). Total chromatin (Input) and samples containing no antibody (No Ab) were included
in the PCR reactions. The PCR products obtained with oligonucleotides specific for the α-actin
promoter and coding region were included as negative controls. Results are representative of
three independent experiments.
Figure 3 NOS-2 mRNA expression in the mammary gland
Expression of NOS-2 (iNOS) mRNA in mammary glands from control lactating rats, rats after
weaning and BSO-treated lactating rats was determined by real-time RT-PCR. GAPDH was used
as an internal control (see the Experimental section). Results are means +− S.E.M. from three
independent experiments. ANOVA was performed for statistical analysis; different superscript
letters indicate significant differences (P < 0.05), and the letter ‘a’ always represents the lowest
value within the group.
RT-PCR was performed using mammary tissue from lactating
and weaned rats. NOS-2 mRNA expression was increased 4-fold
at 8 h after weaning, and remained significantly increased in rats
24 h after weaning (Figure 3).
We have shown that GSH depletion triggers mammary gland
involution, reproducing the changes observed after weaning [6].
To study further the molecular mechanisms of NOS-2 induction
during involution, we analysed the effect of GSH on NOS-2
expression by real-time RT-PCR in lactating rats treated with
BSO, a potent inhibitor of γ -glutamylcysteine synthetase. Admin-
istration of BSO over a period of 2 days inhibited GSH synthesis,
resulting in a significant decrease in GSH levels in the mammary
Figure 4 Effects of weaning and BSO treatment on the levels of NOS-1,
NOS-2 and NOS-3 in the mammary gland
Western blot analysis was performed using whole protein extracts (50 µg) derived from the
mammary tissue of control lactating rats (C), rats 8 and 24 h after weaning (W 8h. and W 24h.
respectively), rats 24 h after weaning followed by resuckling for a further 24 h (W + R 24h.) and
rats treated with BSO over a period of 2 days (BSO 2d.). Extracts were probed with
specific antibodies against NOS-1, NOS-2 and NOS-3 and with anti-α-tubulin. Results are
means +− S.E.M. for three independent experiments. Different superscript letters indicate signifi-
cant differences (P < 0.05); the letter ‘a’ always represents the lowest value within the
group.
gland (control, 2.17 +− 0.15 µmol/g of tissue; BSO-treated, 0.32 +−
0.05 µmol/g; means +− S.E.M.). Interestingly, depletion of GSH
with BSO induced a 3-fold increase in NOS-2 mRNA expression,
reaching similar levels to those observed 8 h after weaning
(Figure 3).
Effects of weaning and BSO treatment on NOS protein levels in the
mammary gland
Since it is known that the cellular half-life of NOS-2 is relatively
short [31], it was important to assess whether the changes observed
in NOS-2 mRNA expression correlated with protein levels. The
three isoforms were studied by Western blot in mammary glands
from rats at the peak of lactation (control), rats at different times
after weaning and BSO-treated rats. NOS-2 protein levels were
increased in a time-dependent manner in the mammary glands of
rats 8 and 24 h after weaning; there was also an increase in NOS-2
protein levels in BSO-treated rats, similar to the values found 8 h
after weaning (Figure 4). In contrast, the protein levels of the NOS-
3 isoform were diminished during weaning and after treatment
with BSO. Interestingly, the changes observed during weaning
were partially reversed towards control values after resuckling for
24 h (Figure 4).
Elevated nitrite production during weaning and following
GSH depletion
Even though NOS-2 is thought to be regulated primarily at the
transcriptional level, other mechanisms of regulation have been
described [8,31]. Therefore NO produced and secreted by the
lactating mammary gland was estimated by measuring the nitrite
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Figure 5 Determination of NO production in the mammary gland under
various experimental conditions
NO production in the mammary gland in control lactating rats (C), rats 8 and 24 h after weaning
(W 8 h. and W 24 h. respectively), rats 24 h after weaning followed by resuckling for a further
24 h (W + R 24h.) and BSO-treated rats (BSO 2d.) was determined by measuring the levels
of nitrite in the mammary gland for at least three rats from each experimental group. Different
superscript letters indicate significant differences (P < 0.05); the letter ‘a’ always represents the
lowest value within the group.
converted from NO. The amounts of NO produced by mam-
mary glands 8 and 24 h after weaning showed a 2-fold increase
compared with the NO produced by mammary glands from
control lactating rats. This increase in NO production during
weaning reverted almost to control values after resuckling for
24 h (Figure 5). Treatment of lactating rats with BSO partially
reproduced the increase in NO formation found during weaning.
This enhancement of NO production in mammary glands follow-
ing weaning and from BSO-treated rats could account for the
observed up-regulation of the NOS-2 isoform (Figure 4).
Appearance of nitrotyrosine-containing proteins in the mammary
gland during involution
As a consequence of NO overproduction, there will be an increase
in reactive species derived from NO. Submicromolar concen-
trations of NO can react with superoxide radical to generate the
potent oxidizing agent peroxynitrite, which can directly attack
various biological targets. In addition, peroxynitrite readily ni-
trates tyrosine residues in proteins, producing a post-translational
modification that might alter protein function, modifying sig-
nal transduction. Western blot analysis of total tissue extracts
from mammary gland demonstrated that nitrotyrosine residues
were increased after weaning, although this increase was limited
to a few specific tyrosine-nitrated proteins of different molecular
masses (see arrows in Figure 6). Interestingly, in this case, the
tyrosine nitration was not reversed after resuckling. The protein
nitration seen in mammary glands from rats at the peak of lactation
treated for 2 days with BSO was similar to that observed in rats
weaned for 8 h (Figure 6).
DISCUSSION
The mammary gland undergoes a highly regulated cascade of
events, going from cell growth to differentiation to apoptosis
during each pregnancy/lactation cycle. This complex evolution
makes this tissue an excellent model in which to study the
regulation of these events, which should be tightly controlled.
It is now widely accepted that NF-κB is essential for proper
development of the mammary tissue [3,13,32]. The activity of this
transcription factor is elevated during pregnancy and involution,
but not during lactation [13]. In fact, activation of NF-κB is one of
the most rapid transcription factor responses in the involution
of the mammary gland, with detectable DNA binding within 2 h
after cessation of suckling [12]. Our results show that, 8 h after
Figure 6 Nitration of proteins in the rat mammary gland
Total proteins (50 µg) extracted from the mammary tissue of control lactating rats (C), rats 8
and 24 h after weaning (W 8 h. and W 24 h. respectively), rats 24 h after weaning followed by
resuckling for a further 24 h (W + R 24 h.) and rats treated with BSO over a period of 2 days (BSO
2d.) were resolved in 10 % (w/v) polyacrylamide gels by reducing SDS/PAGE and examined
by Western blot analysis with a monoclonal antibody against nitrotyrosine. Approximate sizes
(kDa) were estimated using pre-stained molecular-mass markers (left). The arrows indicate
proteins that are clearly nitrated on tyrosine. The Figure is representative of three independent
experiments.
weaning, there was degradation of the major NF-κB inhibitor,
IκBα (Figure 1C), followed by activation of NF-κB in the
mammary gland. Activated NF-κB translocates to the nucleus,
where it binds to specific target genes. We found a 2-fold increase
in the expression of IκBα (Figure 1B), which would modulate the
NF-κB response [10].
A plethora of mouse models have been generated in the
search for key regulators and cell signalling pathways involved in
mammary gland involution [33], although so far these molecular
mechanisms remain to be fully understood. In the present
investigation we have studied the expression of NOS-2, which
is known to have NF-κB binding sites on its promoter [34], and
propose that NO is one of the signalling molecules connecting
hormonal stimuli and milk stasis to biological responses during
involution. Our data show that NF-κB is bound to the NOS-2
promoter during weaning, resulting in the actual transcription
of the gene, as demonstrated by binding of RNA polymerase II to
the coding region of the NOS-2 gene (Figure 2). This result has
been confirmed by real-time PCR, which showed a 4-fold increase
in the expression of the NOS-2 gene in the mammary glands of
rats 8 h after weaning and a 2-fold increase 24 h after weaning
(Figure 3).
The presence of NOS activity has been reported in immuno-
histochemical studies in human [35], goat [36] and rat [37]
mammary glands, where the three isoforms were present in the
epithelial cells of alveoli and lactiferous ducts. We postulate that
NO is generated at a low rate constitutively in the mammary gland
during lactation, mainly by the NOS-3 isoform. This NO produced
at low concentrations is physiological, and may be involved in
mammary gland differentiation and in the regulation of blood
flow to the mammary gland during lactation. However, the protein
levels of this isoform in the mammary gland had declined 24 h
after weaning, whereas NOS-2 levels were increased (Figure 4).
Down-regulation of NOS-3 and an increase in NOS-2 expression
in the rat mammary gland after treatment with lipopolysaccharide
[37], in rat glomerular cells [38] and in cultured bovine coronary
venular endothelial cells [39] has been reported previously. Our
data suggest that this switch in the regulation of the two isoforms
is directly related to the involution of the mammary gland, a
tissue remodelling process that involves apoptosis of mammary
epithelial cells. Overproduction of NO by NOS-2 might trigger
the apoptotic process, inducing p53 activation [40], or result
c© 2005 Biochemical Society
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in the post-translational modification of various proteins, e.g S-
nitrosylation or nitration of tyrosine and tryptophan residues [41].
The process of involution that begins after litter removal is
known to be reversible if pups start suckling again within a short
period of time. However, some of the changes are irreversible if
weaning takes place for longer periods. In fact, lactation will be
maintaned in the mammary gland only by those cells that have
not entered apoptosis at the moment when the resuckling stimuli
appear. In the present study, NOS-2 mRNA expression, protein
levels of the NOS isoforms and NO production that occurred
during weaning were reversed by resuckling to control values.
However, it is noteworthy that protein nitration did not revert to
control values after resuckling, since this protein modification is
irreversible. This is why we still found nitrated proteins under
these conditions, similar to the results observed 24 h after
weaning.
Since GSH depletion induced NOS-2 expression to levels
similar to those induced by weaning, and the molecular switch
between NOS-3 and NOS-2 was partially reproduced by treatment
with BSO, we postulate that GSH status could be behind the
molecular mechanisms leading to NOS-2 induction and/or NOS-
3 repression. We have demonstrated previously that GSH is crucial
for the maintenance of lactation [6,7]. In fact, a decrease in GSH
levels in vivo induces an increase in the expression of p53, p21,
p27, c-Jun and p-JNK (c-Jun N-terminal kinase), and results in
epithelial cell death by apoptosis [6,42]. All of these changes
mimic those found in the lactating mammary gland when pups
are removed, being responsible for mammary gland involution
[6]. It is interesting to note that NO increases during weaning
and after GSH depletion; this could be a potential signal that
triggers involution during weaning and in BSO-treated lactating
rats, lending further support to the importance of maintaining GSH
levels within the physiological range in the lactating mammary
gland.
Although we propose a novel mechanism underlying the initial
events leading to involution of the mammary gland, further
investigation is required to provide information regarding the rel-
evance of these findings in the context of apoptosis and the role
of NO in the signalling events triggered after weaning.
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